Affordable Access

Phase I-II study on isolation antiblastic fotemustine perfusion after dacarbazine chemosensitization for advanced melanoma of the extremities.

Authors
Type
Published Article
Journal
Melanoma Research
0960-8931
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
13
Issue
3
Pages
293–297
Identifiers
PMID: 12777985
Source
Medline

Abstract

Statistics

Seen <100 times